Loading
institutionsInstitution
King Hussein Cancer Center
Jordan's cancer-only hospital and the leading comprehensive cancer centre in the Arab world, the first outside the US accredited as a cancer centre by Joint Commission International.
Also called: KHCCمركز الحسين للسرطان
Overview
The King Hussein Cancer Center in Amman was reorganised in 2001 from the Al-Amal Center under the King Hussein Cancer Foundation and has become the reference cancer centre for Jordan and for patients from across the Middle East, treating adults and children. It was the first cancer centre outside the United States to earn Joint Commission International disease-specific accreditation for oncology, has one of the region's largest paediatric oncology and bone marrow transplant programmes with St. Jude affiliation, and runs a hereditary cancer clinic, a phase 1 unit, PET-CT and radioligand therapy, and Jordan's tobacco control research. KHCC has led regional cooperative research through its Office of Scientific Affairs and the Jordan Cancer Registry, and cares for large numbers of refugees and patients funded by charity.
Location
Amman, JO
Type
cancer center
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#235 · 26 points (0 Newsweek + 0 NCI + 26 from 13 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-15.
Matched to King Hussein Cancer Center, including child institutions. 235 works · 2,160 citations · 69% open access · 9% clinical trials · 7% reviews.
Oncology works per year
382022
372023
502024
632025
472026
Most works
- Akram Al‐Ibraheem44 works
- Hikmat Abdel‐Razeq31 works
- Ahmed Saad Abdlkadir23 works
- Asem Mansour19 works
- Kamal Al-Rabi16 works
- Issa Mohamad16 works
- Maysa Al‐Hussaini15 works
- Rula Amarin15 works
- Maher A. Sughayer14 works
- Mahmoud Al-Masri14 works
Most cited
- Paediatric oncology and transplant
- Regional referral care
- Hereditary cancer clinic
- Tobacco control research
Similar pages
- InstitutionKing Faisal Specialist Hospital and Research Centre
Shares Allogeneic (off-the-shelf) cell therapy, Radioligand therapy (beta emitters), Germline (hereditary) testing, Acute lymphoblastic leukaemia.
- InstitutionRamathibodi Hospital, Mahidol University
Shares Allogeneic (off-the-shelf) cell therapy, Germline (hereditary) testing, Acute lymphoblastic leukaemia, HR-positive / HER2-negative breast cancer.
- InstitutionTata Medical Center, Kolkata
Shares Global oncology and access in low- and middle-income countries, Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Diffuse large B-cell lymphoma.
- InstitutionHospital Universitari i Politècnic La Fe
Shares Allogeneic (off-the-shelf) cell therapy, PET/CT, Germline (hereditary) testing, Acute lymphoblastic leukaemia.
- InstitutionNational Cancer Institute, Cairo University
Shares Global oncology and access in low- and middle-income countries, Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Diffuse large B-cell lymphoma.
- CompanyImugene
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Diffuse large B-cell lymphoma.
- InstitutionHamad Medical Corporation / National Center for Cancer Care and Research
Shares Allogeneic (off-the-shelf) cell therapy, Germline (hereditary) testing, Diffuse large B-cell lymphoma, HR-positive / HER2-negative breast cancer.
- PersonStephen J. Forman
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Diffuse large B-cell lymphoma.